Blog Archives

Events Calendar

Society for Personality and Social Psychology Annual Meeting, Long Beach, CA, February 26-28, 2015

Congressional Briefing – NIH 101: Peer Review & Priority Setting, Washington, DC, February 27, 2015

Academy of Criminal Justice Sciences Annual Meeting, Orlando, FL, March 3-7, 2015

Association of Academic Survey Research Organizations Annual Meeting, New Brunswick, NJ, March 5-7, 2015

COSSA Annual Meeting & Advocacy Day, Washington, DC, March 9-10, 2015

American Psychosomatic Society Annual Scientific Meeting, Savannah, GA, March 18-21, 2015

Society for Research in Child Development Biennial Meeting, Philadelphia, PA, March 19-21, 2015

Southern Sociological Society Annual Meeting, New Orleans, LA, March 25-29, 2015

Association for Asian Studies Annual Conference, Chicago, IL, March 26-29, 2015

Midwest Sociological Society Annual Meeting, Kansas City, MO, March 26-29, 2015

A list of COSSA members’ annual meetings and other events can be found on the COSSA webpage.

COSSA members who have an upcoming event they would like to see listed in the Events Calendar and on our website should send an email to jmilton@cossa.org.

Tagged with: , , , , , , , , ,
Posted in Issue 3 (February 24), Update, Volume 34 (2015)

21st Century Cures Act Discussion Draft Released

House Energy and Commerce Committee Chairman Fred Upton (R-MI) released a discussion draft of the 21st Century Cures Act on January 27. The draft bill is the culmination of a year of hearings and roundtable discussions held by the Committee. Its release was accompanied by a section-by-section discussion of the document and a one-pager highlighting the legislative ideas. The Committee has repeatedly stated that the draft is a “starting point in the legislative process to spur discussion.” Accordingly, they are seeking public feedback on the proposals. The Committee also cautioned that the “inclusion of a policy in the draft should not be seen as an endorsement.” (more…)

Tagged with: , ,
Posted in Issue 3 (February 24), Update, Volume 34 (2015)

Accelerating Biomedical Research Act Introduced in House and Senate

On January 26, Rosa DeLauro (D-CT), Brian Higgins (D-NY), and Peter King (R-NY) reintroduced the bipartisan Accelerating Biomedical Research Act (H.R. 531).The bill “would allow Congress to restore the purchasing power of the National Institutes of Health (NIH)’s funding to what it would have been if it had kept up with inflation since 2003.” It would create a new Budget Control Act cap adjustment for the agency. Any funding provided in excess of $29.4 billion would trigger a budget cap increase to accommodate the additional funding provided. The measure would allow appropriators to increase NIH funding by ten percent for the first two years and about six percent each year thereafter through 2021. DeLauro, who is the Ranking Member of the House Labor, Health and Human Services, Education Appropriations Subcommittee emphasized that, “Work supported by the NIH has saved the lives of countless Americans. Failure to invest in health research and disease prevention results in huge costs to our health, society, economy and knowledge itself. Whether it is cancer, Ebola, or the flu, the benefits of medical research are obvious. Congress must stop forcing the NIH to do more with less.” (more…)

Tagged with: ,
Posted in Issue 3 (February 24), Update, Volume 34 (2015)

Medical Innovation Act Introduced in House and Senate

On January 29, Senators Elizabeth Warren (D-MA), Ben Cardin (D-MD.), Sherrod Brown (D-OH), and Tammy Baldwin (D-WI) introduced the Medical Innovation Act (S.320), which is designed to increase “funding for critical medical research.” A companion bill, H.R. 744, was introduced in the House by Representatives Chris Van Hollen (D-MD), Jan Schakowsky (D-IL), Peter Welch (D-VT), and Kathy Castor (D-FL). According to the press release, the measure would require large pharmaceutical companies that break the law and settle with the federal government to reinvest a small percentage of their profits into the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). Warren stated that, “For decades, American medical research has been a remarkable success, transforming medicine, saving lives, and keeping our families healthy. We can’t allow this engine of innovation to sputter.” The Medical Innovation Act “is an important first step toward breaking Congress’s stalemate over supporting NIH and renewing our nation’s commitment to developing critical medical research,” noted Warren. The bill text is available here and a fact sheet is available here.

Back to this issue’s table of contents.

Tagged with: ,
Posted in Issue 3 (February 24), Update, Volume 34 (2015)

American Cures Act Introduced in Senate

On January 28, Senator Dick Durbin (D-IL) reintroduced the American Cures Act (S. 289). The bill would support research at the National Institutes of Health, the Centers for Disease Control and Prevention, the Department of Defense Health Program, and the Veterans Medical and Prosthetics Research Program. The measure is designed to set a steady growth rate in federal appropriations for biomedical research conducted at these agencies. Annually, the bill would increase funding for each agency and program at a rate of GDP-indexed inflation plus five percent. The “steady, long-term investment” provided by the legislation, if enacted, “would allow the agencies to plan and manage strategic growth while maximizing efficiencies.” The measure is cosponsored by Senators Sherrod Brown (D-OH), Amy Klobuchar (D-MN), Barbara Boxer (D-CA), Edward J. Markey (D-MA), Ben Cardin (D-MD), Al Franken (D-MN), and Bob Casey (D-PA).

Back to this issue’s table of contents.

Tagged with: , ,
Posted in Issue 3 (February 24), Update, Volume 34 (2015)

Senators Release Innovation for Healthier Americans Report, Request Feedback

On January 29, Senators Lamar Alexander (R-TN), Chairman of the Senate Health, Education, Labor and Pensions (HELP) Committee, and Richard Burr (R-NC), released Innovation for Healthier Americans: Identifying Opportunities for Meaningful Reform to Our Nation’s Medical Product Discovery and Development. The report addresses challenges to getting safe treatments, devices, and cures to patients more quickly and effectively, looking specifically at the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). (more…)

Tagged with: , ,
Posted in Issue 3 (February 24), Update, Volume 34 (2015)

HELP Committee Approves Strengthening Education through Research Act

On January 28, the Senate Health, Education, Labor and Pensions (HELP) Committee passed the Strengthening Education through Research Act (S. 227). The bill reauthorizes the Education Sciences Reform Act (ESRA). ESRA authorizes funding for the research activities of the U.S. Department of Education, including the Institute for Education Sciences (IES). The legislation would authorize an appropriation of $612 million for fiscal year (FY) 2016 and $3.2 billion between 2016-2020 to support federal educational research, statistical analysis, and other activities. (more…)

Tagged with: ,
Posted in Issue 3 (February 24), Update, Volume 34 (2015)

Subscribe

Click here to subscribe to the COSSA Washington Update, our biweekly newsletter.

Archive

Looking for something from a previous issue of the COSSA Washington Update? Try our archive.

Issues

Browse by Month